


Dr. Vernon Sondak, MD
book an appointment

Dr. Vernon Sondak, MD
General Surgery
Dr. Vernon Sondak, MD is a general surgeon in Tampa, FL and has over 40 years of experience in the medical field. He graduated from Boston University Chobanian & Avedisian School of Medicine in 1980. He is affiliated with Moffitt Cancer Center Magnolia Campus. He is accepting new patients and telehealth appointments.
Locations
Moffitt Cancer Center, Richard M. Schulze Family Foundation Outpatient Center at McKinley Campus
At a Glance
- Trustworthy • Patients said this doctor is trustworthy. See reviews
- Offers Telehealth • This doctor offers telehealth appointments. Call the office to schedule an appointment.
- Friendly Staff • Patients said the staff was friendly. See reviews
More General Surgery Specialists at Moffitt Cancer Center
Experience Check
Search for experience in a specific area
Dr. Sondak's Reviews
Likelihood to recommend Dr. Sondak
5 star | 71% | 71% |
4 star | 8% | 8% |
3 star | 0% | 0% |
2 star | 4% | 4% |
1 star | 17% | 17% |
Your trust is our top concern.
We strive to keep reviews honest, trustworthy, and fair.Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
- Trusted the provider's decisions
- Appointment scheduling
- Staff friendliness
- Appointment wasn't rushed
- I didn't feel respected
- Didn't listen or answer questions
- Didn't explain conditions well
- Didn't trust the provider's decisions
- Long wait times
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
Leave a review
How was your experience with Dr. Sondak?Is this your profile?
Respond to reviews, add information, and reach more patients. Claiming is free and only takes a minute.
Claim your profileOverall Patient Satisfaction
Likelihood of recommending Dr. Sondak to family and friends is 4.125 out of 5
Insurance Check
Search for your insurance carrier and choose your plan type
About Me
Watch Dr. Sondak's Video
care philosophy
Dr Sondak is Chair of the Department of Cutaneous Oncology at the H Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He holds the Richard M Schulze Family Foundation Distinguished Endowed Chair in Cutaneous Oncology, and is also...read morebiography
Dr. Sondak is Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He holds the Richard M. SchulzeGeneral Surgery
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of California-los Angeles
Fellowship Hospital, 1984Ronald Reagan Ucla Medical Center
Internship Hospital, 1981Boston University Chobanian & Avedisian School Of Medicine
Medical School, 1980
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkThe State of Melanoma: Emergent Challenges and Opportunities, 2021-01-07
Treatment of Head and Neck Melanoma in Situ with Staged Contoured Marginal Excisions, 2016-10-27
Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?, 2018-08-02
The "Great Debate” at Melanoma Bridge 2020: December, 5th, 2020, 2021-04-07
Pediatric Melanoma: Analysis of an International Registry, 2013-09-10
Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression, 2013-03-05
Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma, 2019-09-12
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma, 2020-12-19
Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation, 2016-03-16
Progression of cutaneous melanoma: implications for treatment, 2012-08-15
Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma, 2015-03-26
Behavior of Cutaneous Adnexal Malignancies: A Single Institution Experience, 2018-06-14
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males, 2022-06-03
Conjunctival Melanomas Harbor BRAF and NRAS Mutations-Letter, 2013-10-28
Nonsurgical Treatment Options for Basal Cell Carcinoma, 2011-01-09
High frequency of brain metastases after adjuvant therapy for high-risk melanoma, 2017-10-10
Sentinel node biopsy is indicated for thin melanomas =0.76 mm, 2012-07-06
Cutaneous human papillomaviruses and the risk of keratinocyte carcinomas, 2021-07-15
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review, 2023-04-29
Paradoxical oncogenesis and the long term consequences of BRAF inhibition in melanoma, 2013-05-28
A Brief History of Melanoma: From Mummies to Mutations, 2012-03-06
Ceritinib enhances the efficacy of trametinib inBRAF/NRAS-wild type melanoma cell lines, 2017-11-13
Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma, 2013-03-21
Desmoplastic Melanoma: Is There a Role for Sentinel Lymph Node Biopsy?, 2013-02-07
New challenges in endpoints for drug development in advanced melanoma, 2011-12-05
Radiotherapy Influences Local Control in Patients With Desmoplastic Melanoma, 2013-10-18
The Unique Clinical Characteristics of Melanoma Diagnosed in Children, 2012-08-03
Stratifying SLN incidence in intermediate thickness melanoma patients, 2017-12-14
Combination Therapies for Melanoma: A New Standard of Care?, 2016-02-22
Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?, 2016-03-08